Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats
The chemical components of Xin'an famous prescription Ershen Zhenwu Decoction (ESZWD) are still unclear. The results showed that ESZWD could significantly reduce left ventricular end diastolic diameter, decrease N-terminal pro-brain natriuretic peptide (NT-proBNP), angiotensinII, aldosterone, r...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.913661/full |
_version_ | 1811269739162370048 |
---|---|
author | Li-li Hong Li-li Hong Li-li Hong Li-li Hong Yan Zhao Yan Zhao Yan Zhao Yan Zhao Wei-dong Chen Wei-dong Chen Wei-dong Chen Wei-dong Chen Chen-yu Yang Chen-yu Yang Chen-yu Yang Chen-yu Yang Guo-zhuan Li Guo-zhuan Li Guo-zhuan Li Guo-zhuan Li Hong-song Wang Hong-song Wang Hong-song Wang Hong-song Wang Xiao-yu Cheng |
author_facet | Li-li Hong Li-li Hong Li-li Hong Li-li Hong Yan Zhao Yan Zhao Yan Zhao Yan Zhao Wei-dong Chen Wei-dong Chen Wei-dong Chen Wei-dong Chen Chen-yu Yang Chen-yu Yang Chen-yu Yang Chen-yu Yang Guo-zhuan Li Guo-zhuan Li Guo-zhuan Li Guo-zhuan Li Hong-song Wang Hong-song Wang Hong-song Wang Hong-song Wang Xiao-yu Cheng |
author_sort | Li-li Hong |
collection | DOAJ |
description | The chemical components of Xin'an famous prescription Ershen Zhenwu Decoction (ESZWD) are still unclear. The results showed that ESZWD could significantly reduce left ventricular end diastolic diameter, decrease N-terminal pro-brain natriuretic peptide (NT-proBNP), angiotensinII, aldosterone, reactive oxygen species, and malondialdehyde, increase serum superoxide dismutase, while had no significant effect on inflammatory factors. Ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry (UPLC/Q-TOF-MS) analysis detected 30 prototype components in model rats' serum, mainly including alkaloids, saponins, terpenoids, tanshinones, phenols. UPLC-MS/MS successfully detected the pharmacokinetic parameters of four components, and correlation analysis shows that there are negative correlations between four compounds and serum NT-proBNP. Thirty components of ESZWD may play a therapeutic role in chronic heart failure with heart-kidney Yang deficiency (CHF-HKYd) by improving myocardial injury, reducing oxidative stress levels, and inhibiting activation of the RAAS system in rats. Salsolinol, aconitine, paeoniflorin, and miltrione are equipped with potential characteristics as pharmacodynamic substances for ESZWD in treating CHF-HKYd. Additionally, the constituents of ESZWD in CHF-HKYd rats are different from normal rats, which provided a reference for the selection of subjects for further study. |
first_indexed | 2024-04-12T21:47:22Z |
format | Article |
id | doaj.art-5dadb19f0aa948adbd6212f21affc508 |
institution | Directory Open Access Journal |
issn | 2297-055X |
language | English |
last_indexed | 2024-04-12T21:47:22Z |
publishDate | 2022-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cardiovascular Medicine |
spelling | doaj.art-5dadb19f0aa948adbd6212f21affc5082022-12-22T03:15:34ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-09-01910.3389/fcvm.2022.913661913661Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd ratsLi-li Hong0Li-li Hong1Li-li Hong2Li-li Hong3Yan Zhao4Yan Zhao5Yan Zhao6Yan Zhao7Wei-dong Chen8Wei-dong Chen9Wei-dong Chen10Wei-dong Chen11Chen-yu Yang12Chen-yu Yang13Chen-yu Yang14Chen-yu Yang15Guo-zhuan Li16Guo-zhuan Li17Guo-zhuan Li18Guo-zhuan Li19Hong-song Wang20Hong-song Wang21Hong-song Wang22Hong-song Wang23Xiao-yu Cheng24School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Province Key Laboratory of Chinese Medicinal Formula, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSynergetic Innovation Center of Anhui Authentic Chinese Medicine Quality Improvement, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Province Key Laboratory of Chinese Medicinal Formula, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSynergetic Innovation Center of Anhui Authentic Chinese Medicine Quality Improvement, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Province Key Laboratory of Chinese Medicinal Formula, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSynergetic Innovation Center of Anhui Authentic Chinese Medicine Quality Improvement, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Province Key Laboratory of Chinese Medicinal Formula, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSynergetic Innovation Center of Anhui Authentic Chinese Medicine Quality Improvement, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Province Key Laboratory of Chinese Medicinal Formula, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSynergetic Innovation Center of Anhui Authentic Chinese Medicine Quality Improvement, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSchool of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaAnhui Province Key Laboratory of Chinese Medicinal Formula, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaSynergetic Innovation Center of Anhui Authentic Chinese Medicine Quality Improvement, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaMOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, ChinaDepartment of Geriatric Cardiology, First Affiliated Hospital of Anhui University of Chinese Medicine, Anhui University of Traditional Chinese Medicine, Hefei, ChinaThe chemical components of Xin'an famous prescription Ershen Zhenwu Decoction (ESZWD) are still unclear. The results showed that ESZWD could significantly reduce left ventricular end diastolic diameter, decrease N-terminal pro-brain natriuretic peptide (NT-proBNP), angiotensinII, aldosterone, reactive oxygen species, and malondialdehyde, increase serum superoxide dismutase, while had no significant effect on inflammatory factors. Ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry (UPLC/Q-TOF-MS) analysis detected 30 prototype components in model rats' serum, mainly including alkaloids, saponins, terpenoids, tanshinones, phenols. UPLC-MS/MS successfully detected the pharmacokinetic parameters of four components, and correlation analysis shows that there are negative correlations between four compounds and serum NT-proBNP. Thirty components of ESZWD may play a therapeutic role in chronic heart failure with heart-kidney Yang deficiency (CHF-HKYd) by improving myocardial injury, reducing oxidative stress levels, and inhibiting activation of the RAAS system in rats. Salsolinol, aconitine, paeoniflorin, and miltrione are equipped with potential characteristics as pharmacodynamic substances for ESZWD in treating CHF-HKYd. Additionally, the constituents of ESZWD in CHF-HKYd rats are different from normal rats, which provided a reference for the selection of subjects for further study.https://www.frontiersin.org/articles/10.3389/fcvm.2022.913661/fullErshen Zhenwu Decoctionchronic heart failure with heart-kidney Yang deficiencyUPLC/Q-TOF-MSpharmacokineticpharmacodynamic substances |
spellingShingle | Li-li Hong Li-li Hong Li-li Hong Li-li Hong Yan Zhao Yan Zhao Yan Zhao Yan Zhao Wei-dong Chen Wei-dong Chen Wei-dong Chen Wei-dong Chen Chen-yu Yang Chen-yu Yang Chen-yu Yang Chen-yu Yang Guo-zhuan Li Guo-zhuan Li Guo-zhuan Li Guo-zhuan Li Hong-song Wang Hong-song Wang Hong-song Wang Hong-song Wang Xiao-yu Cheng Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats Frontiers in Cardiovascular Medicine Ershen Zhenwu Decoction chronic heart failure with heart-kidney Yang deficiency UPLC/Q-TOF-MS pharmacokinetic pharmacodynamic substances |
title | Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats |
title_full | Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats |
title_fullStr | Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats |
title_full_unstemmed | Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats |
title_short | Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats |
title_sort | tentative exploration of pharmacodynamic substances pharmacological effects chemical compositions and multi components pharmacokinetic characteristics of eszwd in chf hkyd rats |
topic | Ershen Zhenwu Decoction chronic heart failure with heart-kidney Yang deficiency UPLC/Q-TOF-MS pharmacokinetic pharmacodynamic substances |
url | https://www.frontiersin.org/articles/10.3389/fcvm.2022.913661/full |
work_keys_str_mv | AT lilihong tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT lilihong tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT lilihong tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT lilihong tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT yanzhao tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT yanzhao tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT yanzhao tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT yanzhao tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT weidongchen tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT weidongchen tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT weidongchen tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT weidongchen tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT chenyuyang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT chenyuyang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT chenyuyang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT chenyuyang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT guozhuanli tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT guozhuanli tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT guozhuanli tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT guozhuanli tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT hongsongwang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT hongsongwang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT hongsongwang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT hongsongwang tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats AT xiaoyucheng tentativeexplorationofpharmacodynamicsubstancespharmacologicaleffectschemicalcompositionsandmulticomponentspharmacokineticcharacteristicsofeszwdinchfhkydrats |